{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/rds/general/user/yh4218/home/.conda/envs/NLP/lib/python3.8/site-packages/fuzzywuzzy/fuzz.py:11: UserWarning: Using slow pure-python SequenceMatcher. Install python-Levenshtein to remove this warning\n",
      "  warnings.warn('Using slow pure-python SequenceMatcher. Install python-Levenshtein to remove this warning')\n"
     ]
    }
   ],
   "source": [
    "# -*- coding: utf-8 -*-\n",
    "import os\n",
    "import re\n",
    "from html.parser import HTMLParser\n",
    "from bs4 import BeautifulSoup\n",
    "from bs4 import element\n",
    "from itertools import product\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "from abbreviations import schwartz_hearst\n",
    "import subprocess\n",
    "from fuzzywuzzy import fuzz\n",
    "from fuzzywuzzy import process"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "base_dir = '/rdsgpfs/general/user/yh4218/home/data/NLP'\n",
    "file_list = []\n",
    "def get_files(base_dir,file_list):\n",
    "    files = os.listdir(base_dir)\n",
    "    for i in files:\n",
    "        abs_path = os.path.join(base_dir,i)\n",
    "        if re.match(r'(.*)PMC(.*).html',abs_path):\n",
    "            file_list.append(abs_path)\n",
    "        elif os.path.isdir(abs_path)&('ipynb_checkpoints' not in abs_path):\n",
    "            get_files(abs_path,file_list)\n",
    "    return file_list\n",
    "\n",
    "file_list = get_files(base_dir,file_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "4366"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(file_list)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# All unique H2 heading"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "def extract_all_unique_h2_headings(heading_text_list,soup_og,file_name):\n",
    "    headings = soup_og.find_all('h2')\n",
    "    for number, heading in enumerate(headings):\n",
    "        heading_text =  heading.get_text()\n",
    "        if heading_text not in (heading_texts.split('\\t\\t')[0] for heading_texts in heading_text_list):\n",
    "            heading_text_list.append(heading_text+'\\t\\t'+file_name.split('/')[-1])\n",
    "    return\n",
    "\n",
    "def extract_all_h2_headings(heading_text_list,heading_text_list_with_filename,soup_og,file_name):\n",
    "    headings = soup_og.find_all('h2')\n",
    "    for number, heading in enumerate(headings):\n",
    "        heading_text =  heading.get_text()\n",
    "        heading_text_list.append(''.join([i.lower() for i in heading_text if not i.isdigit()]).strip('.').strip(' ').strip(':').strip(' ').replace('\\n',' '))\n",
    "        heading_text_list_with_filename.append(''.join([i.lower() for i in heading_text if not i.isdigit()]).strip('.').strip(' ').strip(':').strip(' ').replace('\\n',' ')+'thereisaspace'+file_name.split('/')[-1])\n",
    "    return\n",
    "\n",
    "def extract_all_h2_headings(heading_text_list,heading_text_list_with_filename,soup_og,file_name):\n",
    "    headings = soup_og.find_all('h2')\n",
    "    for number, heading in enumerate(headings):\n",
    "        heading_text =  heading.get_text()\n",
    "        heading_text_list.append(''.join([i.lower() for i in heading_text if not i.isdigit()]).strip('.').strip(' ').strip(':').strip(' ').replace('\\n',' '))\n",
    "        heading_text_list_with_filename.append(''.join([i.lower() for i in heading_text if not i.isdigit()]).strip('.').strip(' ').strip(':').strip(' ').replace('\\n',' ')+'thereisaspace'+file_name.split('/')[-1])\n",
    "    return"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# all"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "heading_text_list=[]\n",
    "heading_text_list_with_filename=[]\n",
    "for file in file_list:\n",
    "    #output_file.write(file+'\\n')\n",
    "    with open(file,'r',encoding='UTF-8',errors='ignore') as f:\n",
    "        text = f.read()\n",
    "        soup = BeautifulSoup(text, 'html.parser')\n",
    "        extract_all_h2_headings(heading_text_list,heading_text_list_with_filename,soup,file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "heading_text_list_unique=[]\n",
    "heading_text_list_unique_for_count=[]\n",
    "for number,heading in enumerate(heading_text_list):\n",
    "    number_of_heading = heading_text_list.count(heading)\n",
    "    if number_of_heading >1 and heading_text_list_unique_for_count.count(heading)<1: \n",
    "        heading_text_list_unique.append(heading_text_list_with_filename[number]+'\\t'+str(number_of_heading))\n",
    "        heading_text_list_unique_for_count.append(heading)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['associated data',\n",
       " 'abstract',\n",
       " 'introduction',\n",
       " 'results',\n",
       " 'discussion',\n",
       " 'materials and methods',\n",
       " 'conclusions',\n",
       " 'supplementary materials',\n",
       " 'author contributions',\n",
       " 'funding',\n",
       " 'conflicts of interest',\n",
       " 'references',\n",
       " 'formats',\n",
       " 'share',\n",
       " 'acknowledgments',\n",
       " 'methods',\n",
       " 'patents',\n",
       " 'appendix a',\n",
       " 'results and discussion',\n",
       " 'experimental section',\n",
       " 'conflict of interest',\n",
       " 'lc-ms measurements',\n",
       " 'overview',\n",
       " 'the application in early diagnosis of pancreatic cancer',\n",
       " 'the application in early diagnosis of kidney cancer',\n",
       " 'acknowledgements',\n",
       " 'material and methods',\n",
       " 'abbreviations',\n",
       " 'method',\n",
       " 'authors contributions',\n",
       " 'supplementary material',\n",
       " 'coenzymes analysis in tissue',\n",
       " 'coenzymes in human whole blood',\n",
       " 'subcellular coenzymes',\n",
       " 'supplementary files',\n",
       " 'acknowledgments and disclaimer',\n",
       " 'appendix a. uncertainty analysis',\n",
       " 'author copyright statement',\n",
       " 'experimental',\n",
       " 'references and notes',\n",
       " 'subjects and methods',\n",
       " 'experimental methods',\n",
       " 'data availability',\n",
       " 'ethical approval',\n",
       " 'disclosure',\n",
       " \"authors' contributions\",\n",
       " 'background',\n",
       " 'conclusion',\n",
       " 'footnotes',\n",
       " 'supporting information',\n",
       " 'funding statement',\n",
       " 'glossary',\n",
       " 'table of contents',\n",
       " 'p d-dimer in adult patients with presumed sepsis and their clinical outcomes',\n",
       " 'p diagnosis of infection utilizing acellix cd',\n",
       " 'p high levels of phenylcarboxylic acids reflect the severity in icu patients and affect phagocytic activity of neutrophils',\n",
       " 'p the role of bacterial phenolic metabolites in mitochondrial dysfunction',\n",
       " 'p the early diagnosis of severe sepsis and judgment of rapid transport to critical care center: better prognostic factor',\n",
       " 'p translational neuromodulation of the immune system',\n",
       " 'p pathway-level meta-analysis reveals transcriptional signature of septic shock',\n",
       " 'p antibiotic dosing in septic patients on the critical care unit - a literature review',\n",
       " 'p pandemic of escherichia coli clone o: h-st producing ctx-m- extended spectrum- β- lactamase- as serious cause of multidrug resistance extraintestinal pathogenic e. coli infections in india',\n",
       " 'p detection and characterization of meningitis using a dda-based mass spectrometry approach',\n",
       " 'p diagnostic usefulness of lipid profile and procalcitonin in sepsis and trauma patients',\n",
       " 'p heparin – a novel therapeutic in sepsis?',\n",
       " 'p hypothalamic impairment is associated with vasopressin deficiency during sepsis',\n",
       " 'p presepsin (soluble cd subtype) is a dependable prognostic marker in critical septic patients',\n",
       " 'p safety and efficacy of gelatin-containing solutions versus crystalloids and albumin - a systematic review with quantitative and qualitative summaries',\n",
       " 'p immunomodulatory properties of peripheral blood mesenchymal stem cells following endotoxin stimulation in an equine model',\n",
       " 'p frequency and outcome of early sepsis-associated coagulopathy',\n",
       " 'contributor information',\n",
       " 'electronic supplementary material',\n",
       " 'data availability statement',\n",
       " 'notes',\n",
       " 'competing interests',\n",
       " 'key messages',\n",
       " 'authors’ contributions',\n",
       " 'ethics approval and consent to participate',\n",
       " 'consent for publication',\n",
       " 'publisher’s note',\n",
       " 'ethics',\n",
       " 'statistics',\n",
       " 'grants',\n",
       " 'disclosures',\n",
       " 'additional files',\n",
       " 'ii',\n",
       " 'additional information',\n",
       " 'data analysis',\n",
       " 'study highlights',\n",
       " 'acknowledgment',\n",
       " 'supplementary information',\n",
       " 'to',\n",
       " 'material and method',\n",
       " 'patients and methods',\n",
       " 'data availaiblity',\n",
       " 'methods and materials',\n",
       " 'limitations',\n",
       " 'code availability',\n",
       " 'study limitations',\n",
       " 'targeted analysis',\n",
       " 'global metabolite analysis',\n",
       " 'declarations',\n",
       " 'experimental procedures',\n",
       " 'compliance with ethical standards',\n",
       " 'availability of data and materials',\n",
       " 'summary',\n",
       " 'ethics statement',\n",
       " 'sources of funding',\n",
       " 'statement of interest',\n",
       " 'appendix.\\u2003authors',\n",
       " 'study funding',\n",
       " 'declaration of interest',\n",
       " 'author summary',\n",
       " 'central illustration',\n",
       " 'appendix',\n",
       " 'graphical abstract',\n",
       " 'simple ncbi directory',\n",
       " 'pre-publication history',\n",
       " 'contributorship',\n",
       " 'american college of clinical pharmacology',\n",
       " 'acknowledgement',\n",
       " 'objectives',\n",
       " 'appendix a.\\u2003supplementary material',\n",
       " 'consent',\n",
       " 'summary and conclusion',\n",
       " 'authors’ information',\n",
       " 'conflict of interest statement',\n",
       " 'electronic supplementary materials',\n",
       " 'conflict of interests',\n",
       " \"authors' contribution\",\n",
       " 'comment',\n",
       " 'author contribution',\n",
       " 'transparency',\n",
       " 'authors’ contribution',\n",
       " 'transparency document',\n",
       " 'funding and disclosure',\n",
       " 'background and summary',\n",
       " 'data records',\n",
       " 'technical validation',\n",
       " 'usage notes',\n",
       " 'consortia',\n",
       " 'data citations',\n",
       " \"editors' summary\",\n",
       " 'materials',\n",
       " 'supporting information available',\n",
       " 'study population',\n",
       " 'performance comparison',\n",
       " 'experemintal section',\n",
       " 'sm',\n",
       " 'reference list',\n",
       " 'list of abbreviations',\n",
       " 'toc',\n",
       " 'experimental section*',\n",
       " 'nist lc-ms and lc-ms/ms methods',\n",
       " 'cdc lc-ms/ms method',\n",
       " 'alternate water suppression techniques and avoiding some of their shortcomings',\n",
       " 't filter',\n",
       " 'concluding remarks',\n",
       " 'author present address',\n",
       " 'method validation',\n",
       " 'biological sample testing',\n",
       " 'toc image',\n",
       " 'methods and tools',\n",
       " 'initial data reprocessing',\n",
       " 'ion-pair reinterpretation',\n",
       " 'data comparison',\n",
       " 'putative metabolic pathway analysis',\n",
       " 'analysis of total body irradiation data',\n",
       " 'analysis of colorectal cancer relapse data',\n",
       " 'result and discussion',\n",
       " 'additional file',\n",
       " 'authors contribution',\n",
       " 'supplementary data',\n",
       " 'results and discussions',\n",
       " 'materials & methods',\n",
       " 'funding sources',\n",
       " 'etoc',\n",
       " 'star methods',\n",
       " 'research design and methods',\n",
       " 'article information',\n",
       " 'funding information',\n",
       " 'declaration of interests',\n",
       " 'full text',\n",
       " 'selected references',\n",
       " 'figures and tables',\n",
       " 'methods and design',\n",
       " 'data sharing statement',\n",
       " 'highlights',\n",
       " 'nonstandard abbreviations',\n",
       " 'biographies',\n",
       " 'statistical methods',\n",
       " 'appendix a. supplementary data',\n",
       " 'appendix a.\\u2003supplementary data',\n",
       " 'methods/design',\n",
       " 'research involving human participants',\n",
       " 'ethical approval and consent to participate',\n",
       " 'supplemental information',\n",
       " 'additional information and declarations',\n",
       " \"authors' contributors\",\n",
       " 'declaration of conflicting interests',\n",
       " 'patient consent for publication',\n",
       " 'abbreviations and acronyms',\n",
       " 'data description',\n",
       " 'availability of supporting data and materials',\n",
       " 'competing financial interests',\n",
       " 'consent for publications',\n",
       " 'uhplc-hrms',\n",
       " 'key abbreviations',\n",
       " 'supplemental material',\n",
       " 'guarantor',\n",
       " 'participants and methods',\n",
       " 'clinical perspective',\n",
       " 'version changes',\n",
       " 'version .\\u2003//',\n",
       " 'addendum',\n",
       " 'study groups and methods',\n",
       " 'discussions',\n",
       " 'additional points',\n",
       " 'author contribution statement',\n",
       " 'significance',\n",
       " 'abbreviations list',\n",
       " 'duality of interest',\n",
       " 'results & discussion',\n",
       " 'declaration of competing interest',\n",
       " 'study population and methods',\n",
       " 'comments',\n",
       " 'research in context',\n",
       " 'credit authorship contribution statement',\n",
       " 'acknowledgements & funding',\n",
       " 'appendix.\\u2003supplementary materials',\n",
       " 'supplementary figures and table',\n",
       " 'disclaimer',\n",
       " 'methods and material',\n",
       " 'disclosure of conflict of interest',\n",
       " 'case report',\n",
       " 'perspectives',\n",
       " 'ethics approval',\n",
       " 'metabolic profiling',\n",
       " 'saliva as a diagnostic biofluid',\n",
       " 'lipidomics and salivary lipids',\n",
       " 'analytical methods',\n",
       " 'limitations in lipidome analysis',\n",
       " 'supplementary materials figures and tables',\n",
       " 'discussion and conclusion',\n",
       " \"authors' roles\",\n",
       " 'sustainable and reliable diagnosis: the place of urinary biomarkers for liver cancer diagnosis',\n",
       " 'structural diversity of tri-hydroxyl species',\n",
       " 'lc-ms/ms-based multibiomarker methods',\n",
       " 'analytical challenges',\n",
       " 'application of lc-ms/ms methods in exposure studies',\n",
       " 'outlook',\n",
       " 'experiments and methods',\n",
       " 'algorithm',\n",
       " 'materials and methods*',\n",
       " 'ethical statement',\n",
       " \"publisher's note\",\n",
       " 'nursing implications',\n",
       " 'techniques and analysis of metabolomics',\n",
       " 'metabolomics and models of ibd',\n",
       " 'metabolomics and human ibd',\n",
       " 'urinary metabolomics',\n",
       " 'metabolomics of serum and plasma',\n",
       " 'metabolomics of fecal extracts',\n",
       " 'metabolomics of colon tissue',\n",
       " 'conclusion and perspectives',\n",
       " 'disclosure of potential conflicts of interest',\n",
       " 'accession codes',\n",
       " 'article highlights',\n",
       " 'acknowledgments and funding',\n",
       " 'appendix b',\n",
       " 'appendix c',\n",
       " 'acknoweldgements',\n",
       " 'availability of supporting data',\n",
       " 'data',\n",
       " 'experimental design, materials and methods',\n",
       " 'transparency document.\\u2003supplementary material',\n",
       " 'supplementary materials figures and table',\n",
       " 'methods summary',\n",
       " 'supplementary materials tables',\n",
       " 'supplementary material .',\n",
       " 'discussion and conclusions',\n",
       " 'role of the study sponsor',\n",
       " 'supplementary materials table',\n",
       " 'patient selection',\n",
       " 'neurophysiological assessment',\n",
       " 'neuropsychological assessment',\n",
       " 'neuropsychiatric status',\n",
       " 'nutritional status',\n",
       " 'urinary metabolic profiling by h-nmr spectroscopy',\n",
       " 'phes-positive versus phes-negative patients',\n",
       " 'eeg-positive versus eeg-negative patients',\n",
       " 'ohe versus no ohe (either che or no he)',\n",
       " 'ohe versus patients with cirrhosis and no he',\n",
       " 'che versus patients with cirrhosis and no he',\n",
       " 'informed consent',\n",
       " 'supplementary material and table',\n",
       " 'albumin synthesis, structure, and function',\n",
       " 'introduction to human biomonitoring and history of protein adducts of toxicants',\n",
       " 'generation of reactive metabolites and identification of protein adducts in vitro',\n",
       " 'albumin purification and hydrolysis conditions for adduct studies',\n",
       " 'analytical ms-based instruments and scanning techniques to characterize and quantitate albumin adducts',\n",
       " 'albumin adducts formed with toxicants and carcinogens',\n",
       " 'adduct formation of chemopreventive agents',\n",
       " 'adduct formation with therapeutic drugs',\n",
       " 'endogenous electrophiles',\n",
       " 'challenges and emerging technologies in measuring albumin–toxicant adducts in humans',\n",
       " 'experiments',\n",
       " 'theory/calculation',\n",
       " 'supplementary data .',\n",
       " 'cancer metabolism: at the crossroads of genomics and proteomics',\n",
       " 'metabolism in prostate cancer cells',\n",
       " 'methods in metabolic profiling and imaging',\n",
       " 'future directions and conclusions',\n",
       " 'abbrevation',\n",
       " 'supplementary figures and tables',\n",
       " 'ethical requirements',\n",
       " 'methodology',\n",
       " 'assay application in quantification of clinical human serum samples',\n",
       " '. introduction',\n",
       " '. material and methods',\n",
       " '. discussion',\n",
       " '. conclusions',\n",
       " 'aknowledgments',\n",
       " 'statistical analysis',\n",
       " 'patient and methods',\n",
       " 'literature cited',\n",
       " 'definitions for abbreviations',\n",
       " 'supplementary materials figures',\n",
       " 'clinical applicability',\n",
       " '',\n",
       " 'bottom',\n",
       " 'metabolomics—a window into tumor pathology',\n",
       " 'endogenous estrogen and breast cancer risk',\n",
       " 'early research on estrogen metabolism',\n",
       " 'prospective studies of -hydroxyestrone, α-hydroxyestrone, and breast cancer',\n",
       " 'comprehensive assessment of estrogen metabolism by lc-ms/ms',\n",
       " 'prospective studies of estrogen metabolism and postmenopausal breast cancer',\n",
       " 'prospective studies of estrogen metabolism and premenopausal breast cancer',\n",
       " 'modulating estrogen metabolism',\n",
       " 'medicines from fusarium species',\n",
       " 'exploring fusarium species as sources of antimicrobial agents',\n",
       " 'antiparasitic agents from fusarium species',\n",
       " 'endophytic fungi from fusarium species and their antiviral agents',\n",
       " 'endophytic fungi from fusarium species as sources of novel anticancer compounds',\n",
       " 'antioxidant and antiaging activities of metabolites from fusarium species',\n",
       " 'immunosuppressive and immunomodulator metabolites from fusarium species',\n",
       " 'antithrombotic agents from fusarium species',\n",
       " 'biocontrol ability of endophytic fusarium species',\n",
       " 'disclosure statement',\n",
       " 'supplementary materials figure and table',\n",
       " 'pca metabolomics',\n",
       " 'metabolomic imaging',\n",
       " 'future directions',\n",
       " 'supplementary material figures',\n",
       " 'etoc blurb',\n",
       " 'star methods text',\n",
       " 'methods to measure dna adducts',\n",
       " 'fundamental of the ion trap',\n",
       " 'literature review',\n",
       " 'how to achieve successful measurement',\n",
       " 'conclusions and future directions',\n",
       " 'experiment',\n",
       " 'precis',\n",
       " 'experimetal',\n",
       " 'key points',\n",
       " 'pharmacology',\n",
       " 'brief review of the chemistry and metabolism of opioid pain medications',\n",
       " 'clinical characteristics and metabolism of the opioids most frequently used for chronic pain control',\n",
       " 'semi-synthetic opiates',\n",
       " 'synthetic opioids',\n",
       " 'mr methodologies to study breast tissue metabolism',\n",
       " 'advantages and disadvantages of mrs in the study of tissue metabolism',\n",
       " 'ackowledgment',\n",
       " 'financial support',\n",
       " 'materials and method',\n",
       " 'ambient ionization ms for human cancer tissue imaging and diagnosis',\n",
       " 'biochemical insights into cancer metabolism by ambient ionization ms',\n",
       " 'clinical studies using ambient ionization ms tools',\n",
       " 'perspectives and conclusions',\n",
       " 'material and methods sample collection and reagents',\n",
       " \"authors' information\",\n",
       " 'backgrounds',\n",
       " 'supplementary materials figure',\n",
       " \"author's contributions\",\n",
       " 'study design and methods',\n",
       " 'statistical methods and analysis',\n",
       " 'authorship',\n",
       " 'the abbreviations used',\n",
       " 'conclusions and expert recommendations',\n",
       " 'short summary',\n",
       " 'technologies for the study of metabolism',\n",
       " 'in vivo studies of metabolism',\n",
       " 'metabolic sensors',\n",
       " 'multidisciplinary approaches to study metabolism',\n",
       " 'result',\n",
       " 'reference',\n",
       " 'metabolic fingerprint for aconitase deficiency',\n",
       " 'study design',\n",
       " 'research involving human participants and/or animals',\n",
       " 'strengths and limitations',\n",
       " 'online methods',\n",
       " 'references for main text',\n",
       " 'abbreviation list',\n",
       " 'supplemental methods',\n",
       " 'web site references',\n",
       " 'web resources',\n",
       " 'supplemental data',\n",
       " 'identification of  genome-wide significant loci',\n",
       " 'effects of associated loci on bmi',\n",
       " 'additional associated variants at bmi loci',\n",
       " 'effects of bmi variants on other traits',\n",
       " 'bmi tissues, biological pathways and gene sets',\n",
       " 'extended data',\n",
       " 'main text',\n",
       " 'biography',\n",
       " 'accession numbers',\n",
       " 'future perspective',\n",
       " 'the bipolar genome study (bigs) consortium members',\n",
       " 'profile scoring',\n",
       " 'neighborhood consortium membership list',\n",
       " 'subject and methods',\n",
       " 'mars sample',\n",
       " 'german inpatient replication sample',\n",
       " 'star*d replication sample',\n",
       " 'control subjects for the case/control analysis',\n",
       " 'snp genotyping',\n",
       " 'power calculation',\n",
       " 'pathway analysis',\n",
       " 'abbreviations used',\n",
       " 'ma',\n",
       " 'urls',\n",
       " 'sample',\n",
       " 'variance components modeling of political ideologies',\n",
       " 'genome wide association study of political ideologies',\n",
       " 'concise methods',\n",
       " 'early growth genetics consortium (egg) membership and affiliations',\n",
       " 'early genetics & lifecourse epidemiology (eagle) membership and affiliations',\n",
       " 'cohorts for heart and aging research in genetic epidemiology (charge) membership and affiliations',\n",
       " 'heterozygous individuals with mutations in chst showed early indication of disc abnormalities consistent with degeneration',\n",
       " 'data archiving',\n",
       " 'methods and procedures',\n",
       " '() discovery phase: gwas',\n",
       " 'follow-up study in independent sample',\n",
       " 'statistical analysis for follow-up study and meta-analyses',\n",
       " 'nonstandard abbreviations and acronyms',\n",
       " 'the international schizophrenia consortium',\n",
       " 'genome-wide association and replication testing',\n",
       " 'adiposity and the novel associations with td',\n",
       " 'coding and transcriptional mechanisms at the six novel loci',\n",
       " 'heterogeneity, ld structure and comparisons to europeans',\n",
       " 'six loci associated with td',\n",
       " 'author contribution (in alphabetic order)',\n",
       " 'appendix a supplementary data',\n",
       " 'patients & methods',\n",
       " 'demographic and covariate data',\n",
       " 'international parkinson disease genomics consortium members',\n",
       " 'abbreviations used in this paper',\n",
       " 'study strengths and limitations',\n",
       " 'snp analysis',\n",
       " 'cnv analysis',\n",
       " 'biological pathway enrichment analysis',\n",
       " 'electrophoretic mobility shift assay (emsa)',\n",
       " 'materials andmethods',\n",
       " 'gene-based tests and pathway analysis',\n",
       " 'candidate genes',\n",
       " 'eeg parameters as endophenotypes',\n",
       " 'neurochemical and psychological correlates of eeg parameters',\n",
       " 'candidate gene findings',\n",
       " 'genome-wide studies',\n",
       " 'the current study',\n",
       " 'appendix i',\n",
       " 'methods ',\n",
       " 'results ',\n",
       " 'discussion ',\n",
       " 'supplementary material ',\n",
       " 'funding ',\n",
       " 'acknowledgments ',\n",
       " 'references ',\n",
       " 'role of the funding source',\n",
       " 'ethnic specific results',\n",
       " 'additional analyses',\n",
       " 'antisaccade neurobiology and neuropsychology',\n",
       " 'antisaccade performance as an endophenotype',\n",
       " 'aims of the current study',\n",
       " 'the sigma (slim initiative in genomic medicine for the americas) type  diabetes genetics consortium',\n",
       " 'note added in proof',\n",
       " 'eda as an endophenotype',\n",
       " 'neurobiology of eda',\n",
       " 'molecular genetics and eda',\n",
       " 'appendix a. supplementary material',\n",
       " 'visual abstract',\n",
       " 'megastroke consortium',\n",
       " 'conditional and joint analyses',\n",
       " 'gene set enrichment analysis (gsea)',\n",
       " 'association with other phenotypes',\n",
       " 'proportion of heritability explained',\n",
       " 'life sciences reporting summary',\n",
       " 'data availability and accession code availability',\n",
       " 'gene-based association testing',\n",
       " 'genetic architecture of the plasma proteome',\n",
       " 'overlap of eqtls and pqtls',\n",
       " 'trans pqtls identify pathways to disease',\n",
       " 'causal evaluation of candidate proteins in disease',\n",
       " 'drug target prioritization',\n",
       " 'online content',\n",
       " 'compilance with ethical standards',\n",
       " 'pharmacodynamic modeling of gwas',\n",
       " 'applications',\n",
       " 'conflicts of interests',\n",
       " 'data and methods',\n",
       " 'subjects',\n",
       " 'genotyping and quality control',\n",
       " 'phenotype modeling',\n",
       " 'genome-wide association study',\n",
       " 'gwas meta-analysis',\n",
       " 'in silico replication study',\n",
       " 'estimation of explained variance',\n",
       " 'pleiotropic association analysis for kidney function–related phenotypes',\n",
       " 'appendix: duke perioperative genetics and safety outcomes (pegasus) investigative team members',\n",
       " 'appendix: members of the bmdcs',\n",
       " 'methods for the mec smokers gwas',\n",
       " 'methods for the tricl lung cancer gwas consortium',\n",
       " 'materials, subjects and methods',\n",
       " \"authors' disclosures of potential conflicts of interest\",\n",
       " 'authors’ disclosures of potential conflicts of interest',\n",
       " 'main authors by consortium and author contributions',\n",
       " 'methods only references',\n",
       " 'eating disorders working group of the psychiatric genomics consortium',\n",
       " 'methods-only references',\n",
       " 'abreviations',\n",
       " 'appendix.',\n",
       " 'non-standard abbreviations',\n",
       " 'introductory paragraph',\n",
       " 'sample & methods',\n",
       " 'detailed methods',\n",
       " 'references for detailed methods',\n",
       " 'abbreviation and acronyms',\n",
       " 'funding summary and acknowledgments',\n",
       " 'online methods references',\n",
       " 'author disclosure statement',\n",
       " 'participants',\n",
       " 'genotyping',\n",
       " 'clopidogrel metabolite quantification',\n",
       " 'platelet aggregation']"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "heading_text_list_unique_for_count"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 111,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open('/rdsgpfs/general/user/yh4218/home/data/all_unique_h2_headings_with_counts.txt','w') as f:\n",
    "    for heading in heading_text_list_unique:\n",
    "        f.write(str(heading)+'\\n')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# unique"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [],
   "source": [
    "heading_text_list=[]\n",
    "for file in file_list:\n",
    "    #output_file.write(file+'\\n')\n",
    "    with open(file,'r',encoding='UTF-8',errors='ignore') as f:\n",
    "        text = f.read()\n",
    "        soup = BeautifulSoup(text, 'html.parser')\n",
    "        extract_all_unique_h2_headings(heading_text_list,soup,file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open('/rdsgpfs/general/user/yh4218/home/data/all_unique_h2_headings.txt','w') as f:\n",
    "    for heading in heading_text_list:\n",
    "        f.write(str(heading)+'\\n')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Find not classified heading"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Appendix A\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Metabolites (Journal)/PMC6724101.html\n",
      "4. LC-MS Measurements\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Metabolites (Journal)/PMC5618317.html\n",
      "Appendix A. Uncertainty Analysis\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Metabolites (Journal)/PMC6918257.html\n",
      "Author Copyright Statement\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Metabolites (Journal)/PMC6918257.html\n",
      "2. The Application in Early Diagnosis of Pancreatic Cancer\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Metabolites (Journal)/PMC3901290.html\n",
      "3. The Application in Early Diagnosis of Kidney Cancer\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Metabolites (Journal)/PMC3901290.html\n",
      "2. Coenzymes Analysis in Tissue\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Metabolites (Journal)/PMC6027050.html\n",
      "3. Coenzymes in Human Whole Blood\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Metabolites (Journal)/PMC6027050.html\n",
      "4. Subcellular Coenzymes\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Metabolites (Journal)/PMC6027050.html\n",
      "Notes\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC6143519.html\n",
      "Contributor Information\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC6143519.html\n",
      "Ethics\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4500934.html\n",
      "Statistics\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4500934.html\n",
      "Ethics approval and consent to participate\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC6518644.html\n",
      "Consent for publication\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC6518644.html\n",
      "Publisher’s Note\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC6518644.html\n",
      "Supporting information\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC5846776.html\n",
      "Table of contents\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P1 D-Dimer in adult patients with presumed sepsis and their clinical outcomes\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P2 Diagnosis of infection utilizing Acellix CD64\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P3 High levels of phenylcarboxylic acids reflect the severity in ICU patients and affect phagocytic activity of neutrophils\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P4 The role of bacterial phenolic metabolites in mitochondrial dysfunction\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P5 The early diagnosis of severe sepsis and judgment of rapid transport to critical care center: better prognostic factor\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P6 Translational neuromodulation of the immune system\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P7 Pathway-level meta-analysis reveals transcriptional signature of septic shock\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P8 Antibiotic dosing in septic patients on the critical care unit - a literature review\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P9 Pandemic of Escherichia coli clone O25: H4-ST131 producing CTX-M-15 extended spectrum- β- lactamase- as serious cause of multidrug resistance extraintestinal pathogenic E. coli infections in India\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P10 Detection and characterization of meningitis using a DDA-based mass spectrometry approach\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P11 Diagnostic usefulness of lipid profile and procalcitonin in sepsis and trauma patients\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P12 Heparin – a novel therapeutic in sepsis?\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P13 Hypothalamic impairment is associated with vasopressin deficiency during sepsis\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P14 Presepsin (soluble CD14 subtype) is a dependable prognostic marker in critical septic patients\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P15 Safety and efficacy of gelatin-containing solutions versus crystalloids and albumin - a systematic review with quantitative and qualitative summaries\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P16 Immunomodulatory properties of peripheral blood mesenchymal stem cells following endotoxin stimulation in an equine model\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "P17 Frequency and outcome of early sepsis-associated coagulopathy\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4895252.html\n",
      "Key messages\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4340832.html\n",
      "GRANTS\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC3023293.html\n",
      "Data Analysis\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4537695.html\n",
      "Ethical Approval\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC6875220.html\n",
      "Study Highlights\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4893679.html\n",
      "Supporting Information\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/sepsis (Trait)/PMC4723089.html\n",
      "Data Availaiblity\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Scientific Reports (Journal)/PMC6411723.html\n",
      "Limitations\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Scientific Reports (Journal)/PMC6113282.html\n",
      "Study Limitations\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Scientific Reports (Journal)/PMC6692400.html\n",
      "Targeted Analysis\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Scientific Reports (Journal)/PMC5175266.html\n",
      "Global Metabolite Analysis\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Scientific Reports (Journal)/PMC5175266.html\n",
      "Declarations\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Scientific Reports (Journal)/PMC5567318.html\n",
      "Compliance with ethical standards\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC6756100.html\n",
      "Author Summary\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC4564198.html\n",
      "Ethics Statement\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC7001531.html\n",
      "Simple NCBI Directory\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC5475765.html\n",
      "Pre-publication history\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC3199239.html\n",
      "Contributorship\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC5132144.html\n",
      "American College of Clinical Pharmacology\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC5132144.html\n",
      "Consent\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC6507152.html\n",
      "Summary\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC6996235.html\n",
      "Author summary\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC6312347.html\n",
      "Appendix. Authors\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC6550500.html\n",
      "Central Illustration\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC5811927.html\n",
      "Appendix\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC5811927.html\n",
      "APPENDIX A\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC4297593.html\n",
      "Compliance with Ethical Standards\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC5684259.html\n",
      "Comment\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC3279728.html\n",
      "2. Objectives\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC4443390.html\n",
      "Transparency document\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC4802395.html\n",
      "Data records\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC6244184.html\n",
      "Technical validation\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC6244184.html\n",
      "Usage Notes\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC6244184.html\n",
      "Consortia\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC6244184.html\n",
      "Data Citations\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC6244184.html\n",
      "Transparency\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC4937660.html\n",
      "Editors' Summary\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC1551919.html\n",
      "Authors’ information\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/neurodegenerative, psychiatric, and brain illnesses (Trait)/PMC3893491.html\n",
      "Supporting Information Available\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Journal of Proteome Research (Journal)/PMC6184476.html\n",
      "2. Study Population\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Journal of Proteome Research (Journal)/PMC3719870.html\n",
      "Performance Comparison\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Journal of Proteome Research (Journal)/PMC2941198.html\n",
      "Experemintal Section\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Journal of Proteome Research (Journal)/PMC4286171.html\n",
      "Concluding Remarks\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical Chemistry (Journal)/PMC3690541.html\n",
      "Author Present Address\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical Chemistry (Journal)/PMC3690541.html\n",
      "TOC image\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical Chemistry (Journal)/PMC5358966.html\n",
      "Biological Sample Testing\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical Chemistry (Journal)/PMC6503468.html\n",
      "Initial Data Reprocessing\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical Chemistry (Journal)/PMC4519008.html\n",
      "Ion-Pair Reinterpretation\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical Chemistry (Journal)/PMC4519008.html\n",
      "Data Comparison\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical Chemistry (Journal)/PMC4519008.html\n",
      "Putative Metabolic Pathway Analysis\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical Chemistry (Journal)/PMC4519008.html\n",
      "Analysis of Total Body Irradiation Data\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical Chemistry (Journal)/PMC4519008.html\n",
      "Analysis of Colorectal Cancer Relapse Data\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical Chemistry (Journal)/PMC4519008.html\n",
      "4. Concluding remarks\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical Chemistry (Journal)/PMC3705959.html\n",
      "TOC\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical Chemistry (Journal)/PMC5663283.html\n",
      "Alternate Water Suppression Techniques and\n",
      "Avoiding Some of\n",
      "Their Shortcomings\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical Chemistry (Journal)/PMC5588096.html\n",
      "T2 Filter\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical Chemistry (Journal)/PMC5588096.html\n",
      "Article Information\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC4806771.html\n",
      "Data sharing statement\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6732562.html\n",
      "Authors' contributors\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC3599233.html\n",
      "Patient consent for publication\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6777336.html\n",
      "Data Description\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC5502363.html\n",
      "Data analysis\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC5502363.html\n",
      "Concluding remarks\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC5571542.html\n",
      "Research involving human participants\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC5571542.html\n",
      "Ethical approval\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6822198.html\n",
      "Guarantor\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6822198.html\n",
      "Clinical Perspective\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC5287439.html\n",
      "Version Changes\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6629294.html\n",
      "Version 1. 06/04/2019\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6629294.html\n",
      "Version 2. 07/11/2019\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6629294.html\n",
      "ADDENDUM\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC3507576.html\n",
      "Consent for Publications\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6402886.html\n",
      "Full Text\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC1729870.html\n",
      "Figures and Tables\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC1729870.html\n",
      "Biographies\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6762021.html\n",
      "SUMMARY\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6636917.html\n",
      "eTOC\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6636917.html\n",
      "Research in context\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6938899.html\n",
      "Significance\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC4115565.html\n",
      "Highlights\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC3573235.html\n",
      "COMMENTS\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC5467075.html\n",
      "Perspectives\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC4053470.html\n",
      "Ethics approval\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6280838.html\n",
      "2. Saliva as a Diagnostic Biofluid\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6914909.html\n",
      "3. Lipidomics and Salivary Lipids\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6914909.html\n",
      "5. Limitations in Lipidome Analysis\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6914909.html\n",
      "Version 1. 10/01/2019\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6948762.html\n",
      "Version 2. 11/01/2019\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6948762.html\n",
      "Ethical approval and consent to participate\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6614008.html\n",
      "2.2 Metabolic profiling\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC3840107.html\n",
      "Authors' roles\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC4991660.html\n",
      "1. Case Report\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC6101507.html\n",
      "SUSTAINABLE AND RELIABLE DIAGNOSIS: THE PLACE OF URINARY BIOMARKERS FOR LIVER CANCER DIAGNOSIS\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC4651910.html\n",
      "UHPLC-HRMS\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC5986816.html\n",
      "Disclaimer\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/metabolic syndrome (Trait)/PMC5974275.html\n",
      "Compliance with ethical standards \t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical and Bioanalytical Chemistry (Journal)/PMC6314687.html\n",
      "3.7. Structural diversity of tri-hydroxyl species\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical and Bioanalytical Chemistry (Journal)/PMC6424582.html\n",
      "Analytical challenges\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical and Bioanalytical Chemistry (Journal)/PMC3695324.html\n",
      "Outlook\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Analytical and Bioanalytical Chemistry (Journal)/PMC3695324.html\n",
      "3. Algorithm\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Journal of Chromatography A (Journal)/PMC3933977.html\n",
      "Full text\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Proceedings of the National Academy of Sciences of the United States of America (Journal)/PMC344824.html\n",
      "Ethical Statement\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/gastrointestinal (Trait)/PMC6150202.html\n",
      "Nursing Implications\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/gastrointestinal (Trait)/PMC5472373.html\n",
      "Techniques and analysis of metabolomics\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/gastrointestinal (Trait)/PMC3693066.html\n",
      "Metabolomics and models of IBD\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/gastrointestinal (Trait)/PMC3693066.html\n",
      "Metabolomics and human IBD\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/gastrointestinal (Trait)/PMC3693066.html\n",
      "Urinary metabolomics\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/gastrointestinal (Trait)/PMC3693066.html\n",
      "Metabolomics of serum and plasma\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/gastrointestinal (Trait)/PMC3693066.html\n",
      "Metabolomics of fecal extracts\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/gastrointestinal (Trait)/PMC3693066.html\n",
      "Metabolomics of colon tissue\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/gastrointestinal (Trait)/PMC3693066.html\n",
      "Publisher's Note\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/gastrointestinal (Trait)/PMC5641999.html\n",
      "Accession codes\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/gastrointestinal (Trait)/PMC5046165.html\n",
      "ARTICLE HIGHLIGHTS\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC6626731.html\n",
      "5. Concluding remarks\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5730072.html\n",
      "ROLE OF THE STUDY SPONSOR\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC3715109.html\n",
      "Patient selection\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5346407.html\n",
      "Neurophysiological assessment\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5346407.html\n",
      "Neuropsychological assessment\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5346407.html\n",
      "Neuropsychiatric status\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5346407.html\n",
      "Nutritional status\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5346407.html\n",
      "Urinary metabolic profiling by 1H-NMR spectroscopy\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5346407.html\n",
      "PHES-positive versus PHES-negative patients\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5346407.html\n",
      "EEG-positive versus EEG-negative patients\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5346407.html\n",
      "OHE versus no OHE (either cHE or no HE)\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5346407.html\n",
      "OHE versus patients with cirrhosis and no HE\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5346407.html\n",
      "cHE versus patients with cirrhosis and no HE\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5346407.html\n",
      "APPENDIX\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC4373661.html\n",
      "Ethical requirements\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC4927592.html\n",
      "Informed consent\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC4927592.html\n",
      "1. Albumin Synthesis, Structure, and Function\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5241710.html\n",
      "3. Generation of Reactive Metabolites and Identification of Protein\n",
      "Adducts in Vitro\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5241710.html\n",
      "4. Albumin\n",
      "Purification and Hydrolysis Conditions for Adduct Studies\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5241710.html\n",
      "5. Analytical MS-Based Instruments and Scanning Techniques to Characterize\n",
      "and Quantitate Albumin Adducts\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5241710.html\n",
      "6. Albumin Adducts Formed with Toxicants and Carcinogens\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5241710.html\n",
      "7. Adduct Formation of Chemopreventive Agents\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5241710.html\n",
      "8. Adduct\n",
      "Formation with Therapeutic Drugs\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5241710.html\n",
      "9. Endogenous Electrophiles\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5241710.html\n",
      "10. Challenges\n",
      "and Emerging Technologies in Measuring Albumin–Toxicant Adducts\n",
      "in Humans\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5241710.html\n",
      "2. Experiments\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5528483.html\n",
      "3. Data analysis\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5528483.html\n",
      "Aknowledgments\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC6719621.html\n",
      "Statistical analysis\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC3392760.html\n",
      "4. Clinical applicability\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC6085835.html\n",
      "2. Metabolomics—a window into tumor pathology\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5696311.html\n",
      "3. Concluding remarks\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5696311.html\n",
      "Endogenous estrogen and breast cancer risk\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5722219.html\n",
      "Early research on estrogen metabolism\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5722219.html\n",
      "Prospective studies of 2-hydroxyestrone, 16α-hydroxyestrone, and breast cancer\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5722219.html\n",
      "Comprehensive assessment of estrogen metabolism by LC-MS/MS\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5722219.html\n",
      "Prospective studies of estrogen metabolism and postmenopausal breast cancer\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5722219.html\n",
      "Prospective studies of estrogen metabolism and premenopausal breast cancer\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5722219.html\n",
      "Modulating estrogen metabolism\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5722219.html\n",
      "1. Medicines from Fusarium species\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC7033707.html\n",
      "2. Exploring fusarium species as sources of antimicrobial agents\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC7033707.html\n",
      "3. Antiparasitic agents from fusarium species\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC7033707.html\n",
      "4. Endophytic fungi from fusarium species and their antiviral agents\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC7033707.html\n",
      "5. Endophytic fungi from fusarium species as sources of novel anticancer compounds\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC7033707.html\n",
      "6. Antioxidant and antiaging activities of metabolites from fusarium species\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC7033707.html\n",
      "7. Immunosuppressive and immunomodulator metabolites from fusarium species\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC7033707.html\n",
      "8. Antithrombotic agents from fusarium species\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC7033707.html\n",
      "9. Biocontrol ability of endophytic fusarium species\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC7033707.html\n",
      "Statistical Analysis\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC2556963.html\n",
      "FUNDAMENTAL OF THE ION TRAP\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5027840.html\n",
      "LITERATURE REVIEW\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5027840.html\n",
      "HOW TO ACHIEVE SUCCESSFUL MEASUREMENT\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5027840.html\n",
      "LITERATURE CITED\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5027840.html\n",
      "PCa Metabolomics\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC3690591.html\n",
      "Metabolomic Imaging\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC3690591.html\n",
      "Future Directions\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC3690591.html\n",
      "Precis:\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC6402983.html\n",
      "Key Points\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC6755532.html\n",
      "2. Theory/calculation\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5528498.html\n",
      "4. Assay application in quantification of clinical human serum samples\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5924413.html\n",
      "BRIEF REVIEW OF THE CHEMISTRY AND METABOLISM OF OPIOID PAIN MEDICATIONS\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC4975244.html\n",
      "CLINICAL CHARACTERISTICS AND METABOLISM OF THE OPIOIDS MOST FREQUENTLY USED FOR CHRONIC PAIN CONTROL\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC4975244.html\n",
      "SEMI-SYNTHETIC OPIATES\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC4975244.html\n",
      "SYNTHETIC OPIOIDS\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC4975244.html\n",
      "Experiment\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5766651.html\n",
      "3. Concluding Remarks\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC6173511.html\n",
      "eTOC blurb\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC6239935.html\n",
      "Ambient Ionization MS for Human Cancer Tissue Imaging and Diagnosis\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5315420.html\n",
      "Biochemical Insights into Cancer Metabolism by Ambient Ionization MS\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5315420.html\n",
      "Clinical Studies Using Ambient Ionization MS Tools\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5315420.html\n",
      "1. \t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC7070802.html\n",
      "Abbrevation\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5095026.html\n",
      "2. Experimetal\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5124534.html\n",
      "Appendix B\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC6471231.html\n",
      "Appendix C\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC6471231.html\n",
      "Authorship\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC3682342.html\n",
      "Cancer Metabolism: At the crossroads of genomics and proteomics\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC4306198.html\n",
      "Metabolism in Prostate Cancer Cells\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC4306198.html\n",
      "4. Clinical applicability\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC6114173.html\n",
      "Ackowledgment\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC3175039.html\n",
      "Technologies for the study of metabolism\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5938018.html\n",
      "In vivo studies of metabolism\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5938018.html\n",
      "Metabolic sensors\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5938018.html\n",
      "Multidisciplinary approaches to study metabolism\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5938018.html\n",
      "Short summary\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC3651533.html\n",
      "Result\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC4694296.html\n",
      "1. Data\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5338865.html\n",
      "Data description\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC4418095.html\n",
      "3. Advantages and Disadvantages of MRS in the Study of Tissue Metabolism\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC5487996.html\n",
      "Authors' information\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC6777689.html\n",
      "Literature Cited\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC4231431.html\n",
      "Pharmacology\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/cancer (Trait)/PMC4338777.html\n",
      "Metabolic fingerprint for aconitase deficiency\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/PLOS One (Journal)/PMC5413020.html\n",
      "Study Design\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/PLOS One (Journal)/PMC4364783.html\n",
      "Research involving human participants and/or animals\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Metabolomics (Journal)/PMC6133122.html\n",
      "5. Concluding remarks\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Metabolomics (Journal)/PMC7122646.html\n",
      "Informed Consent\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Metabolomics (Journal)/PMC5025509.html\n",
      "CONCLUDING REMARKS\t/rdsgpfs/general/user/yh4218/home/data/NLP-MWAS/Metabolomics (Journal)/PMC4624446.html\n"
     ]
    }
   ],
   "source": [
    "discard_list=['funding',\n",
    "              'Conflicts of Interest',\n",
    "              #'Additional Information',\n",
    "              'Acknowledgment',\n",
    "              'Acknowledgement',\n",
    "              'financial',\n",
    "              'contribution',\n",
    "              'conflict',\n",
    "              'footnotes',\n",
    "              'interest',\n",
    "              'Reference',\n",
    "              'Formats',\n",
    "              'Share',\n",
    "              'Patent',\n",
    "              'disclosure',\n",
    "              'Availability',\n",
    "              'additional']\n",
    "abstract_list=['abstract']\n",
    "introduction_list=['introduction']\n",
    "background_list=['background']\n",
    "overview_list=['overview']\n",
    "supplementary_material_list=['supplementary','Associated Data','Supplemental']\n",
    "abbreviation_list=['glossary','abbreviation']\n",
    "method_material_list=['method','material','Experimental'] # sometimes titled Experimental section & procedure \n",
    "result_discussion_list=['Results','discussion']\n",
    "conclusion_list=['conclusion']  # sometimes with future direction\n",
    "all_list=discard_list+abstract_list+introduction_list+background_list+overview_list+supplementary_material_list+abbreviation_list+method_material_list+result_discussion_list+conclusion_list\n",
    "newlist=[]\n",
    "match=[]\n",
    "for heading in heading_text_list:\n",
    "    #newlist.append(heading.split('\\t')[0])\n",
    "    newlist.append(heading)\n",
    "with open('/rdsgpfs/general/user/yh4218/home/outputs/all_unique_h2_headings.txt','w') as output_file:\n",
    "    for heading in newlist:\n",
    "        if not any(word.lower() in heading.lower() for word in all_list):\n",
    "            match.append(heading)\n",
    "for m in match:print (m)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "93"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "fuzz.ratio(\"Acknowledgement\",\"Acknowledgment\")\n",
    "fuzz.partial_ratio(\"Acknowledgement\",\"Acknowledgment\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "NLP",
   "language": "python",
   "name": "nlp"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
